학술논문
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection.
Document Type
Article
Author
Source
Pathogens & Global Health; Jul2022, Vol. 116 Issue 5, p297-304, 8p
Subject
Language
ISSN
20477724
Abstract
Copyright of Pathogens & Global Health is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)